As a member of a patient community deeply impacted by Digestive Tract Paralysis, including conditions such as Gastroparesis and Chronic Intestinal Pseudo-Obstruction, I have witnessed countless individuals suffer needlessly due to the lack of appropriate and available treatments. Despite living in a nation renowned for medical advancements, our community's cries for help have been consistently met with silence within the walls of the regulatory bodies that hold the power to bring meaningful change.

The United States Food and Drug Administration (FDA) is a crucial entity responsible for ensuring the safety and efficacy of medications. However, its current structure does not adequately prioritize or address the urgent needs of patients waiting in despair for life-altering treatments. The absence of a dedicated Office of the Patient Advocate within the FDA often leaves patients navigating through a bureaucratic maze, without a voice to champion their needs and concerns at a policy-making level.

An Office of the Patient Advocate would bridge this gap, ensuring that patient communities are represented and have a direct line of communication with those who hold the authority to approve and fast-track treatments. This office would not only facilitate faster access to medication but would also make sure that patient experiences and needs are taken into account during the drug approval process. It is essential for the FDA to embrace a more patient-centered approach to uphold its duty of care towards all citizens.

The implementation of such an office is especially crucial for those suffering from rare and under-researched conditions, such as ours. We have long been marginalized and overlooked, and the establishment of a Patient Advocate within the FDA could potentially revolutionize how swiftly we receive treatments that can drastically improve our quality of life.

Time and time again, studies have shown that patient involvement in the decision-making process improves outcomes and promotes better health solutions. Now is the time for the FDA to step up and acknowledge us not merely as numbers on a chart, but as human beings whose lives are valuable and worth listening to.

We urge you to support the creation of an Office of the Patient Advocate within the FDA. Join us in our fight for timely access to effective and safe treatments for all patient communities. Together, we can ensure a voice where it matters the most. Please sign this petition and help us make change a reality.